A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
Year: 2001
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: H.J. Mackay, A. McInnes, J. Paul, N. Raby, F.J. Lofts, A.C. McDonald, M. Soukop, G.M. Fullarton, A.L. Harris, J. Garcia-Vargas, T.R.J. Evans
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: AstraZeneca
OpenAlex ID: W2148615569
